France 2030 logo

France 2030

Europe, Rhone-Alpes, France, Villeurbanne

Description

France 2030 is the Investments for the Future programme (PIA) aim to stimulate employment.

Investor Profile

France 2030 has made 30 investments, with 10 in the past 12 months and 57% as lead.

Stage Focus

  • Grant (67%)
  • Debt Financing (10%)
  • Seed (10%)
  • Series Unknown (3%)
  • Series B (3%)
  • Series A (3%)
  • Post Ipo Debt (3%)

Country Focus

  • France (93%)
  • The Netherlands (3%)
  • United States (3%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Health Care
  • Medical
  • Biopharma
  • Software
  • Semiconductor
  • Energy
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does France 2030 frequently co-invest with?

European Commission
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Innovacom
Europe, Ile-de-France, France, Paris
Co-Investments: 1
CA
Europe, Rhone-Alpes, France, Grenoble
Co-Investments: 1
C
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Quantonation
Europe, Ile-de-France, France, Paris
Co-Investments: 2
BNP Paribas
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 6
Crédit Agricole
Europe, Ile-de-France, France, Montrouge
Co-Investments: 2
CEA Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
CD
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1

What are some of recent deals done by France 2030?

Allogenica

Lyon, Rhone-Alpes, France

Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.

AnalyticsBiopharmaBiotechnology
GrantMar 19, 2025
Amount Raised: $2,735,607
Egle Therapeutics

Paris, Ile-de-France, France

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

BiotechnologyHealth CareOncologyTherapeutics
GrantMar 17, 2025
Amount Raised: $10,118,308
Abionyx Pharma

Balma, Midi-Pyrenees, France

ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.

BiotechnologyHealth Care
GrantFeb 20, 2025
Amount Raised: $9,075,726
Withings

Issy-les-moulineaux, Ile-de-France, France

Withings is a developer of digital health and wellness smart devices such as fitness trackers and watches.

AppsConsumer ElectronicsHealth CareSoftwareWellness
GrantDec 4, 2024
Amount Raised: $21,760,383
Gleamer

Paris, Ile-de-France, France

Gleamer develops medical grade AI for Radiology

Artificial Intelligence (AI)Software
GrantDec 4, 2024
Amount Raised: $4,730,518
ImCheck Therapeutics

Marseille, Provence-Alpes-Cote d'Azur, France

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
GrantAug 29, 2024
Amount Raised: $22,359,838
Chipiron

Paris, Ile-de-France, France

Chipiron is a company that designs, manufactures, and markets a new generation of portable, inexpensive and powerful MRI machines.

Emergency MedicineHealth CareHealth DiagnosticsHome Health CareManufacturingMedicalMedical DevicePersonal Health
GrantJul 15, 2024
Amount Raised: $2,723,641
Crossject

Dijon, Bourgogne, France

Crossject specializes in manufacturing and marketing needleless drug self-injection.

Manufacturing
Post Ipo DebtJul 10, 2024
Amount Raised: $7,465,141
SEEDERAL Technologies

Verny, Lorraine, France

Seederal Technologies is an agricultural machinery manufacturing company that produces electric tractors.

Machinery ManufacturingManufacturing
GrantApr 25, 2024
Amount Raised: $3,968,897
Apmonia Therapeutics

Reims, Champagne-Ardenne, France

Apmonia Therapeutics is a biotech company that develops therapeutic strategies for cancer.

BiotechnologyTherapeutics
GrantApr 23, 2024
Amount Raised: $2,889,635